Information  X 
Enter a valid email address

ONCIMMUNE (ONC)

Date Time Source Announcement
31 Jul 2020 7:00 am
RNS
ERJ publishes results from the ECLS study
27 Jul 2020 7:00 am
RNS
Roche Contract Expansion to Profile Autoantibodies
24 Jul 2020 2:52 pm
RNS
Exercise of Options and Total Voting Rights
08 Jul 2020 7:00 am
RNS
Paper highlights potential of ImmunoINSIGHTS in RA
01 Jul 2020 7:00 am
RNS
Authorisation for EarlyCDT Lung in Brazil
30 Jun 2020 7:00 am
RNS
Exercise of Options
09 Jun 2020 3:54 pm
RNS
Grant of Options and PDMR notification
08 Jun 2020 7:00 am
RNS
Holdings in Company
05 Jun 2020 2:00 pm
RNS
Price Monitoring Extension
  9:02 am
RNS
CORRECTION: Director/PDMR's Dealing
  7:00 am
RNS
Director/PDMR's Dealing
04 Jun 2020 7:00 am
RNS
Trading Update for 12 months to 31 May 2020
02 Jun 2020 4:09 pm
RNS
Holding(s) in Company
29 May 2020 2:40 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Notice of Trading Update
28 May 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Contract with Roche to Profile Autoantibodies
21 May 2020 7:00 am
RNS
EarlyCDT Lung Partnership Contract Signed
14 May 2020 7:00 am
RNS
Featured Presentation at ASCO 2020 Virtual Meeting
12 May 2020 7:00 am
RNS
Drug Development Collaboration Agreement Signed
06 May 2020 8:56 am
RNS
PDMR Dealing
04 May 2020 5:08 pm
RNS
Directorate Change
01 May 2020 10:32 am
RNS
Grant of Options and PDMR notification
24 Apr 2020 3:59 pm
RNS
Director/PDMR Shareholding
07 Apr 2020 11:41 am
RNS
PDMR Dealing
01 Apr 2020 10:31 am
RNS
PDMR Dealing
25 Mar 2020 12:42 pm
RNS
PDMR Dealing
20 Mar 2020 2:09 pm
RNS
Holding(s) in Company
18 Mar 2020 5:42 pm
RNS
Holding(s) in Company
  12:19 pm
RNS
PDMR Dealing
17 Mar 2020 10:24 am
RNS
NICE concludes review of EarlyCDT Lung
13 Mar 2020 11:42 am
RNS
Issue of Equity
12 Mar 2020 6:31 pm
RNS
PDMR / PCA Dealings
04 Mar 2020 7:00 am
RNS
US Commercial Launch
02 Mar 2020 3:35 pm
RNS
Director/PDMR's Dealing
21 Feb 2020 7:00 am
RNS
'Winning in Business in Spain' Award
18 Feb 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
14 Feb 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  11:55 am
RNS
Holding(s) in Company
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
12 Feb 2020 7:00 am
RNS
Half Year Report
28 Jan 2020 7:00 am
RNS
Lung Test More Cost Effective Compared to CT
27 Jan 2020 7:00 am
RNS
Notice of Capital Markets Update
23 Jan 2020 12:30 pm
RNS
Consortium of Liver Cancer Industry Leaders
07 Jan 2020 7:00 am
RNS
Notice of Half Year Results
  7:00 am
RNS
Change of Registered Address
12 Dec 2019 2:07 pm
RNS
Winner of BioNewsRound Award
29 Nov 2019 9:58 am
RNS
Results of Annual General Meeting
04 Nov 2019 2:46 pm
RNS
Notice of AGM and Posting of Annual Report
  7:00 am
RNS
Draw down of second tranche of credit facility
01 Nov 2019 7:10 am
RNS
Oncimmune and Biodesix seal deal
31 Oct 2019 7:00 am
RNS
Final Results
25 Oct 2019 7:00 am
RNS
Notice of Full Year Results ended May 2019
16 Oct 2019 5:01 pm
RNS
Oncimmune welcomes NHS review of cancer screenings
23 Sep 2019 7:00 am
RNS
Key appointments to further strengthen management
20 Sep 2019 2:32 pm
RNS
Appointment of Joint Broker
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t